A $5.5 Billion Fund Dumps These 3 Stocks

Key TakeawaysVestal Point Capital, a firm managing $5. 47 billion, held none of its Abbott Laboratories, Revolution Medicines or BioCryst Pharmaceuticals shares by Sept.

Nov 21, 2026 - 15:00
 0  0
A $5.5 Billion Fund Dumps These 3 Stocks
Key TakeawaysVestal Point Capital, a firm managing $5. 47 billion, held none of its Abbott Laboratories, Revolution Medicines or BioCryst Pharmaceuticals shares by Sept.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow